[
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) Outpaced the Stock Market Today",
    "summary": "In the most recent trading session, Boston Scientific (BSX) closed at $91.07, indicating a +1.35% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=74b4497fd65369f42b74d669b4072c8159aa139f7df50cd4e2a48731844d3971",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735081216,
      "headline": "Why Boston Scientific (BSX) Outpaced the Stock Market Today",
      "id": 132142714,
      "image": "https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Boston Scientific (BSX) closed at $91.07, indicating a +1.35% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=74b4497fd65369f42b74d669b4072c8159aa139f7df50cd4e2a48731844d3971"
    }
  },
  {
    "ts": null,
    "headline": "4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow",
    "summary": "Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.",
    "url": "https://finnhub.io/api/news?id=4ed270554e20706457f289850eb993fe8a084f981d2ab5c1c9be6b672dd67044",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735049340,
      "headline": "4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow",
      "id": 132132998,
      "image": "https://media.zenfs.com/en/zacks.com/b693231ec652d955b89ef0825efe25b1",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.",
      "url": "https://finnhub.io/api/news?id=4ed270554e20706457f289850eb993fe8a084f981d2ab5c1c9be6b672dd67044"
    }
  }
]